Clinical Trial Update: Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating single and multiple ascending doses of AMG 786 in healthy participants and participants with obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• AMG 786

Snippet

Sponsor: Amgen | Conditions: Obesity | Phase 1 | Status: COMPLETED